Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Betterlife Pharma Inc (BETR.CN)

Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 11,068
  • Shares Outstanding, K 130,216
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,889 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $0.00 on 12/31/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0800 +6.25%
on 03/11/25
0.1100 -22.73%
on 03/05/25
-0.0250 (-22.73%)
since 02/21/25
3-Month
0.0800 +6.25%
on 03/11/25
0.1750 -51.43%
on 01/23/25
-0.0200 (-19.05%)
since 12/20/24
52-Week
0.0800 +6.25%
on 03/11/25
0.1950 -56.41%
on 08/28/24
-0.0150 (-15.00%)
since 03/21/24

Most Recent Stories

More News
BetterLife Announces Debt Conversions

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)
USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)
BetterLife Announces Favorable Outcome in New York Legal Claims

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)
BetterLife Obtains Favourable Cardiac Safety Data for BETR-001

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)
BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge...

BETRF : 0.0583 (-22.37%)
BETR.CN : 0.0850 (unch)
BetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - BetterLife Pharma (CSE: BETR), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for...

BETRF : 0.0583 (-22.37%)
BETR.CN : 0.0850 (unch)
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference

VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain

VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.0850 (unch)
BETRF : 0.0583 (-22.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary...

See More

Key Turning Points

3rd Resistance Point 0.0850
2nd Resistance Point 0.0850
1st Resistance Point 0.0850
Last Price 0.0850
1st Support Level 0.0850
2nd Support Level 0.0850
3rd Support Level 0.0850

See More

52-Week High 0.1950
Fibonacci 61.8% 0.1511
Fibonacci 50% 0.1375
Fibonacci 38.2% 0.1239
Last Price 0.0850
52-Week Low 0.0800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar